Adrenocortical carcinoma: past, present, and future (Q37999696)

26 August 2017

title

Adrenocortical carcinoma: past, present, and future (English)

1 reference

26 August 2017

main subject

adrenocortical carcinoma

1 reference

2

1 reference

26 August 2017

1

Jennifer Lafemina

1 reference

26 August 2017

publication date

3 April 2012

1 reference

Journal of Surgical Oncology

26 August 2017

published in

1 reference

26 August 2017

volume

106

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

586-594

1 reference

Mitotane Use in Inoperable Adrenal Cortical Carcinoma

26 August 2017

cites work

1 reference

Prevalence and natural history of adrenal incidentalomas

21 January 2018

1 reference

Trends in adrenalectomy: a recent national review

21 January 2018

1 reference

21 January 2018

Adrenocortical carcinoma

1 reference

Adrenocortical carcinoma: clinical and laboratory observations

21 January 2018

1 reference

Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry

21 January 2018

1 reference

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

21 January 2018

1 reference

Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group

21 January 2018

1 reference

Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature

21 January 2018

1 reference

Clinical review: Adrenocortical carcinoma: clinical update

21 January 2018

1 reference

Genotyping of Adrenocortical Tumors: Very Frequent Deletions of the MEN1 Locus in 11q13 and of a 1-Centimorgan Region in 2p16

21 January 2018

1 reference

Adrenocortical cancer: pathophysiology and clinical management

21 January 2018

1 reference

21 January 2018

Adrenocortical cancer

1 reference

Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma

21 January 2018

1 reference

Management of the clinically inapparent adrenal mass ("incidentaloma")

21 January 2018

1 reference

Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT.

21 January 2018

1 reference

MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors

21 January 2018

1 reference

Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience

21 January 2018

1 reference

11C-metomidate PET imaging of adrenocortical cancer

21 January 2018

1 reference

Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.

21 January 2018

1 reference

Adrenal masses in the cancer patient: surveillance or excision

21 January 2018

1 reference

Management of adrenocortical carcinoma

21 January 2018

1 reference

Insights into the role of genetic alterations in adrenocortical tumorigenesis.

21 January 2018

1 reference

Practical considerations in the evaluation and management of adrenocortical cancer

21 January 2018

1 reference

MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy

21 January 2018

1 reference

Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling

21 January 2018

1 reference

Mortality in surgically treated adrenocortical tumors. II. Review of cases reported for the 20 year period 1930-1949, inclusive

21 January 2018

1 reference

Adrenocortical carcinoma with intracaval extension

21 January 2018

1 reference

Thoracoabdominal-median sternotomy for resection of primary adrenal carcinoma extending into inferior vena cava and hepatic vein

21 January 2018

1 reference

Laparoscopic lateral adrenalectomy versus open posterior adrenalectomy for the treatment of benign adrenal tumors

21 January 2018

1 reference

Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program

21 January 2018

1 reference

A comparison of open vs laparoscopic adrenalectomy

21 January 2018

1 reference

Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer.

21 January 2018

1 reference

Adjuvant mitotane treatment for adrenocortical carcinoma

21 January 2018

1 reference

Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane

21 January 2018

1 reference

Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use.

21 January 2018

1 reference

Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma

21 January 2018

1 reference

Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma

21 January 2018

1 reference

A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.

21 January 2018

1 reference

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial

21 January 2018

1 reference

Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma

21 January 2018

1 reference

Radiotherapy in adrenocortical carcinoma

21 January 2018

1 reference

A twelve-year experience with adrenal cortical carcinoma in a single institution: long-term survival after surgical treatment and transcatheter arterial embolization.

21 January 2018

1 reference

Disrupting insulin-like growth factor signaling as a potential cancer therapy

21 January 2018

1 reference

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

21 January 2018

1 reference

Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer

21 January 2018

1 reference

Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy

21 January 2018

1 reference

Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients

21 January 2018

1 reference

Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma.

21 January 2018

1 reference

Adrenocortical Carcinoma: Clinical, Morphologic, and Molecular Characterization

21 January 2018

1 reference

Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients

21 January 2018

1 reference

Efficacy of Adjuvant Radiotherapy of the Tumor Bed on Local Recurrence of Adrenocortical Carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.23112

1 reference

26 August 2017

1 reference